XML 32 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows
 6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
OPERATING ACTIVITIES:    
Net income (loss) $ 662,000,000 $ (223,000,000)
Adjustments to net income (loss):    
Depreciation, amortization, and accretion of AROs 867,000,000 691,000,000
Deferred Income Tax Expense (Benefit) 26,000,000 149,000,000
Emissions Allowance Expense 94,000,000 178,000,000
Loss on realized/unrealized foreign currency (4,000,000) 24,000,000
Other 101,000,000 220,000,000
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (206,000,000) 26,000,000
(Increase) decrease in inventory (36,000,000) (29,000,000)
(Increase) decrease in prepaid expenses and other current assets 578,000,000 198,000,000
(Increase) decrease in other assets 81,000,000 75,000,000
Increase (decrease) in accounts payable and other current liabilities (34,000,000) (116,000,000)
Increase (decrease) in income tax payables, net, and other tax payables (264,000,000) (82,000,000)
Increase (decrease) in other liabilities (14,000,000) 83,000,000
Net cash provided by operating activities 2,247,000,000 1,521,000,000
INVESTING ACTIVITIES:    
Capital expenditures (3,409,000,000) (2,586,000,000)
Payments to Acquire Businesses and Interest in Affiliates 21,000,000 112,000,000
Proceeds from Divestiture of Businesses and Interests in Affiliates 233,000,000 5,000,000
Sale of short-term investments 129,000,000 52,000,000
Purchase of short-term investments (1,000,000) (36,000,000)
Payments to Acquire Intangible Assets (223,000,000) (234,000,000)
Other investing 29,000,000 29,000,000
Net cash used in investing activities (3,263,000,000) (2,882,000,000)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities 2,826,000,000 2,128,000,000
Repayments under the revolving credit facilities (1,982,000,000) (2,398,000,000)
Proceeds from (Repayments of) Commercial Paper (79,000,000) 67,000,000
Issuance of recourse debt 1,800,000,000 800,000,000
Repayments of recourse debt (1,300,000,000) (774,000,000)
Issuance of non-recourse debt 1,424,000,000 2,332,000,000
Repayments of non-recourse debt (720,000,000) (1,490,000,000)
Payments for financing fees (65,000,000) (49,000,000)
Purchases under supplier financing arrangements (669,000,000) (567,000,000)
Repayments of obligations under supplier financing arrangements 448,000,000 862,000,000
Distributions to noncontrolling interests (1,238,000,000) (338,000,000)
Contributions from noncontrolling interests 128,000,000 274,000,000
Sales to Noncontrolling Interests 306,000,000 1,138,000,000
Issuance of Preferred Shares in Subsidiaries 282,000,000 452,000,000
Dividends paid on AES common stock (251,000,000) (250,000,000)
Payments for financed capital expenditures (58,000,000) (21,000,000)
Other financing (53,000,000) (114,000,000)
Net cash provided by financing activities 1,241,000,000 1,462,000,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4,000,000) (5,000,000)
Net Cash Change Of Discontinued And Held For Sale Businesses 0 66,000,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 221,000,000 162,000,000
Cash, cash equivalents and restricted cash, beginning 2,162,000,000 2,039,000,000
Cash, cash equivalents and restricted cash, ending 2,383,000,000 2,201,000,000
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 620,000,000 598,000,000
Cash payments for income taxes, net of refunds 200,000,000 134,000,000
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Noncash or Part Noncash Divestiture, Amount of Consideration Received 16,000,000 11,000,000
Receivable for proceeds from sale of Dominican Republic Renewables 0 100,000,000
Lease Obligation Incurred 120,000,000 78,000,000
Liability derecognized due to sale of assets 0  
Capital Expenditures Incurred but Not yet Paid 761,000,000 611,000,000
Noncash contributions from noncontrolling interest related to tax credit transfers 496,000,000 212,000,000
Noncash distributions to noncontrolling interests 69,000,000 45,000,000
Non-cash contributions from noncontrolling interests 0 42,000,000
Other current assets, net of allowance of $2 and $2, respectively 1,351,000,000  
Loss (gain) on realized/unrealized derivatives 23,000,000 71,000,000
Sales-type Lease, Selling Profit (Loss) 44,000,000 208,000,000
Gain on disposal and sale of business interests (209,000,000) (69,000,000)
Asset, Impairment Loss $ 42,000,000 $ (95,000,000)